These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Adalimumab for the prevention and/or treatment of post-operative recurrence of Crohn's disease: a prospective, two-year, single center, pilot study. Papamichael K, Archavlis E, Lariou C, Mantzaris GJ. J Crohns Colitis; 2012 Oct; 6(9):924-31. PubMed ID: 22424843 [Abstract] [Full Text] [Related]
6. Prevention of postoperative recurrence with azathioprine or infliximab in patients with Crohn's disease: an open-label pilot study. Armuzzi A, Felice C, Papa A, Marzo M, Pugliese D, Andrisani G, Federico F, De Vitis I, Rapaccini GL, Guidi L. J Crohns Colitis; 2013 Dec; 7(12):e623-9. PubMed ID: 23810678 [Abstract] [Full Text] [Related]
7. [Azathioprine for prevention of postoperative recurrence in Crohn's disease]. Abdelli MN, Ben Abdallah H, Houissa F, Bouali MR, Khediri MF. Tunis Med; 2007 Jul; 85(7):569-72. PubMed ID: 18064988 [Abstract] [Full Text] [Related]
8. [5-Aminosalicylic acid in the prevention of recurrences of Crohn's disease]. Del Corso L, Moruzzo D, Romanelli AM, Norpoth M, Pentimone F, Bresci G. Dtsch Med Wochenschr; 1995 Dec 15; 120(50):1723-7. PubMed ID: 8542807 [Abstract] [Full Text] [Related]
12. Anastomotic configuration and mucosal 5-aminosalicyclic acid (5-ASA) concentrations in patients with Crohn's disease: a GISC study. Gruppo Italiano per lo Studio del Colon e del Retto. Frieri G, Pimpo MT, Palumbo G, Tonelli F, Annese V, Sturniolo GC, Andreoli A, Comberlato M, Corrao G, Caprilli R. Am J Gastroenterol; 2000 Jun 15; 95(6):1486-90. PubMed ID: 10894584 [Abstract] [Full Text] [Related]
13. Coated oral 5-aminosalicylic acid versus placebo in maintaining remission of inactive Crohn's disease. International Mesalazine Study Group. Aliment Pharmacol Ther; 1990 Feb 15; 4(1):55-64. PubMed ID: 2104074 [Abstract] [Full Text] [Related]
14. Current treatment for prevention of relapse and recurrence in Crohn's disease. Prantera C, Scribano ML. Ital J Gastroenterol Hepatol; 1999 Feb 15; 31(6):515-8. PubMed ID: 10575572 [Abstract] [Full Text] [Related]
16. Efficacy of azathioprine versus mesalazine in postoperative Crohn's disease-the authors' response. Reinisch W, Stange EF, International AZT-2 Study Group. Gut; 2011 May 15; 60(5):739-40. PubMed ID: 21363886 [No Abstract] [Full Text] [Related]
17. Budesonide versus mesalamine for maintaining remission in patients refusing other immunomodulators for steroid-dependent Crohn's disease. Mantzaris GJ, Petraki K, Sfakianakis M, Archavlis E, Christidou A, Chadio-Iordanides H, Triadaphyllou G. Clin Gastroenterol Hepatol; 2003 Mar 15; 1(2):122-8. PubMed ID: 15017504 [Abstract] [Full Text] [Related]
18. Infliximab heals intestinal inflammatory lesions and restores growth in children with Crohn's disease. Borrelli O, Bascietto C, Viola F, Bueno de Mesquita M, Barbato M, Mancini V, Bosco S, Cucchiara S. Dig Liver Dis; 2004 May 15; 36(5):342-7. PubMed ID: 15191204 [Abstract] [Full Text] [Related]
19. [Postoperative recurrence in Crohn's disease]. Caprilli R, Taddei G, Viscido A. Chir Ital; 1995 May 15; 47(5):25-32. PubMed ID: 9162601 [Abstract] [Full Text] [Related]